CVOT, notable for comparing the two drugs, tirzepatide showed significantly greater improvements in major kidney outcomes vs dulaglutide.

Please provide your email address to receive an email when new articles are posted on . Semaglutide lowered risk for kidney outcomes consistently across BMI subgroups in the FLOW trial. Body weight ...

H OUSTON -- Rate of successful kidney transplantation was similar in adults, ages 65 and older, who received a lower dose ...

Benefits seen particularly for younger patients and for reducing racial disparities in access to kidney transplants.

Substantial reductions in adverse cardiovascular outcomes are especially notable for this high-risk population, but ...

An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney ...

Empagliflozin stabilizes kidney function and reduces heart failure risk post-myocardial infarction, with eGFR remaining stable over 24 months. The EMPACT-MI trial confirmed empagliflozin's safety when ...

The results of two large-scale studies demonstrate that sodium-glucose co-transporter 2 (SGLT2) inhibitors significantly ...

Maintaining adequate hydration is crucial for efficient kidney function, helping to filter waste and balance electrolytes.

A meta-analysis reveals a significant link between chronic kidney disease (CKD) and gastroesophageal reflux disease (GERD), highlighting the need for increased screening and awareness. Nurses enhance ...